GS0051: Pharmaceutical preparations for the treatment of oncology, endocrinology, neurology, rare diseases, gastroenterology, cardiovascular and cognitive disorders
Case File Event Statements
4/27/2023 - a year ago
55 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
4/27/2023 - a year ago
54 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDType:MAB2
4/27/2023 - a year ago
53 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
10/13/2022 - 2 years ago
52 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
10/13/2022 - 2 years ago
51 - NON-FINAL ACTION E-MAILEDType:GNRT
10/13/2022 - 2 years ago
50 - SU - NON-FINAL ACTION - WRITTENType:CNRT
9/21/2022 - 2 years ago
49 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
9/16/2022 - 2 years ago
48 - USE AMENDMENT FILEDType:IUAF
9/16/2022 - 2 years ago
47 - TEAS STATEMENT OF USE RECEIVEDType:EISU
3/11/2022 - 2 years ago
46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
3/10/2022 - 2 years ago
45 - SOU EXTENSION 5 GRANTEDType:EX5G
3/1/2022 - 2 years ago
44 - SOU EXTENSION 5 FILEDType:EXT5
3/10/2022 - 2 years ago
43 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
3/1/2022 - 2 years ago
42 - TEAS EXTENSION RECEIVEDType:EEXT
1/20/2022 - 2 years ago
41 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
1/20/2022 - 2 years ago
40 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINSType:EWAF